EVALCHEMIST
Turnover and EBIT margin are not published. The micro format does not require them. The turnover shown is an estimate from the gross margin.
Turnover ≈ €76,000. Estimated: probably between €35,000 and €180,000.
Balance sheet
balance sheet total €15,464 on 31-12-2025Position in the sector
19.4%
Higher than 26% of 666 companies in 2025.
1.19
Higher than 26% of 626 companies in 2025.
38.5%
Higher than 87% of 641 companies in 2025.
Net result: middle half · Equity: bottom quarter · Balance sheet total: bottom quarter · Working capital: bottom quarter
Filed annual accounts
as filed with the National Bank, click a year to choose it| Line | Trend | 2025 |
|---|---|---|
| Balance sheet: assets | ||
20/58 |
15,464 | |
20 |
598 | |
29/58 |
14,865 | |
40/41 |
8,997 | |
40 |
8,400 | |
41 |
597 | |
54/58 |
4,485 | |
490/1 |
1,383 | |
| Balance sheet: equity and liabilities | ||
10/49 |
15,464 | |
10/15 |
3,000 | |
10/11 |
3,000 | |
17/49 |
12,464 | |
42/48 |
12,464 | |
44 |
563 | |
440/4 |
563 | |
45 |
5,155 | |
450/3 |
2,130 | |
454/9 |
3,025 | |
47/48 |
6,746 | |
| Income statement | ||
9900 |
10,257 | |
630 |
598 | |
640/8 |
400 | |
9901 |
9,259 | |
65/66B |
1,463 | |
65 |
1,463 | |
9903 |
7,796 | |
67/77 |
1,844 | |
9904 |
5,951 | |
9905 |
5,951 | |
| Appropriation of the result | ||
9906 |
5,951 | |
694/7 |
5,951 | |
694 |
5,951 | |
| Document | ||
The notes to these accounts have 1 item. You find them in the accounts filed with the NBB.
Source: Annual accounts 2025 at the NBB, filed on 05-06-2026.
Filings
each dot is a set of accounts, on the day it reached the National Bank| Financial year | Type | Filed | Reference | Document |
|---|---|---|---|---|
| 31-12-2025 | micro format | 05-06-2026 | 2026-00151131 |
Key figures and ratios
per financial year, computed from the annual accounts| Line | Trend | 2025 |
|---|---|---|
| 9,857 | ||
| 6,550 | ||
| 2,402 | ||
| 19.4% | ||
| 1.19 | ||
| 4.15 | ||
| 198.4% | ||
| 38.5% | ||
| 6.74 |
A Belgian filing has no cash-flow statement. Cash flow is therefore an approximation, derived from the income statement. Investment is the acquisitions in the notes and, without them, the balance-sheet move.
Insights on EVALCHEMIST
Debt's share of the balance-sheet total is 80.6%.